Imagen de Portada

Interplay of physical and recognition performance using hierarchical continuous‐time dynamic modeling and a dual‐task training regime in Alzheimer's patients

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Svenja Schwarck, Manuel C. Voelkle, Andreas Becke, Nancy Busse, Wenzel Glanz, Emrah Düzel, Gabriel Ziegler
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Fully automated MRI‐based analysis of the locus coeruleus in aging and Alzheimer's disease dementia using ELSI‐Net
por: Max Dünnwald, et al.
Publicado: (2025)

Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline
por: Stefan J. Teipel, et al.
Publicado: (2024)

Automated remote speech‐based testing of individuals with cognitive decline: Bayesian agreement of transcription accuracy
por: Alexandra König, et al.
Publicado: (2024)

A systematic review and meta‐analysis of dual‐task outcomes in subjective cognitive decline
por: Talia Salzman, et al.
Publicado: (2025)

Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology
por: Lara Blömeke, et al.
Publicado: (2024)

Diagnostic performance of light reflex pupillometry in Alzheimer's disease
por: Mathias Holsey Gramkow, et al.
Publicado: (2024)

Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome
por: Emily K. Schworer, et al.
Publicado: (2024)

Rest‐activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women
por: Alexandra Paget‐Blanc, et al.
Publicado: (2025)

Delayed primacy recall performance predicts post mortem Alzheimer's disease pathology from unimpaired ante mortem cognitive baseline
por: Davide Bruno, et al.
Publicado: (2024)

Association of apolipoprotein E genotype with cognitive performance: findings from the University of California, Davis Alzheimer's Disease Research Center longitudinal diversity cohort
por: Eva Min, et al.
Publicado: (2026)

Diagnostic utility of plasma p‐tau217 differs by Alzheimer's disease tau‐based subtypes
por: Seyed Hani Hojjati, et al.
Publicado: (2025)

Impact of dual sensory impairment on dementia: A systematic review and meta‐analysis
por: Daniele Urso, et al.
Publicado: (2026)

The role of cerebrovascular reactivity on brain activation during a working memory task in type 2 diabetes
por: Yarden Oliel, et al.
Publicado: (2025)

Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer's disease in the Alzheimer's Disease Sequencing Project: Study design and methodology
por: Nicholas R. Ray, et al.
Publicado: (2024)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
por: María A. Rodríguez‐Santiago, et al.
Publicado: (2024)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
por: Juliana N. Souza‐Talarico, et al.
Publicado: (2025)

Vision and hearing difficulty and effects of cognitive training in older adults
por: Alison R. Huang, et al.
Publicado: (2024)

Association between BrainAGE and Alzheimer's disease biomarkers
por: Yousaf Abughofah, et al.
Publicado: (2025)

General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
por: Thomas Claessen, et al.
Publicado: (2025)

Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease
por: Diana Esteller‐Gauxax, et al.
Publicado: (2026)

Treating Alzheimer's disease in a person living with HIV
por: David B. Clifford, et al.
Publicado: (2026)

Interchangeability of CSF and PET to identify Alzheimer's disease pathology
por: Samantha C. Burnham, et al.
Publicado: (2026)

The classification of mild cognitive impairment or healthy ageing improves when including practice effects derived from a semantic verbal fluency task
por: Felix Dörr, et al.
Publicado: (2025)

Cerebrospinal fluid sclerostin levels in the early Alzheimer's disease stages
por: Manuela Dicarlo, et al.
Publicado: (2026)

Cerebrospinal fluid soluble insulin receptor levels in Alzheimer's disease
por: Peter Thomas, et al.
Publicado: (2024)

Alzheimer's disease neuropathology and longitudinal change in subjective cognitive complaints
por: Alisa Bannerjee, et al.
Publicado: (2025)

Longitudinal changes in functional capacity in frontotemporal dementia and Alzheimer's disease
por: David Foxe, et al.
Publicado: (2024)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
por: Sofia Toniolo, et al.
Publicado: (2024)

Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly
por: Andrée‐Ann Baril, et al.
Publicado: (2024)

Commentary on “It is time to share Alzheimer biomarker results in dementia with Lewy bodies”
por: John T. O'Brien
Publicado: (2025)

Navigating late‐stage dementia: A perspective from the Alzheimer's Association
por: Kristen Clifford, et al.
Publicado: (2024)

Caregivers’ attitudes toward blood‐based biomarker testing for Alzheimer's disease
por: Katharina Bolsewig, et al.
Publicado: (2024)

Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
por: Darren M. Lipnicki, et al.
Publicado: (2026)

Non‐Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism
por: Sebastiaan De Keersmaecker, et al.
Publicado: (2024)

Real‐world experience with lecanemab therapy for Alzheimer's disease in the Intermountain West
por: Bethany C. Curd, et al.
Publicado: (2026)

Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
por: Ying Xia, et al.
Publicado: (2025)

Machine learning models of Alzheimer's disease spectrum using blood tests
por: Nicola Walter Falasca, et al.
Publicado: (2025)

Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
por: Willa D. Brenowitz, et al.
Publicado: (2026)

Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
por: Soheil Mohammadi, et al.
Publicado: (2025)

White matter hyperintensities in Alzheimer's disease in the era of anti‐amyloid therapies
por: Antoine Garnier‐Crussard, et al.
Publicado: (2026)